Cumberland Pharmaceuticals Inc financial data

Symbol
CPIX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2525 West End Avenue, Suite 950, Nashville,, TN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 140 % -18.2%
Quick Ratio 20.6 % -47.3%
Debt-to-equity 177 % +22.2%
Return On Equity -35.1 % -627%
Return On Assets -12.6 % -539%
Operating Margin -13.6 % +36.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.1M shares -1.92%
Common Stock, Shares, Outstanding 14.1M shares -1.73%
Entity Public Float 12.1M USD -30.3%
Common Stock, Value, Issued 47.2M USD -0.73%
Weighted Average Number of Shares Outstanding, Basic 14.1M shares -1.92%
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares -3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 42M USD +16.7%
Revenue from Contract with Customer, Excluding Assessed Tax 37.8M USD -7.05%
Research and Development Expense 5.41M USD -6.21%
Selling and Marketing Expense 17.9M USD +8.92%
General and Administrative Expense 10.9M USD +3.47%
Costs and Expenses 48.7M USD +8.95%
Operating Income (Loss) -10.9M USD -168%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.3M USD -480%
Income Tax Expense (Benefit) 54.8K USD -20.5%
Net Income (Loss) Attributable to Parent -10.4M USD -481%
Earnings Per Share, Basic -0.73 USD/shares -462%
Earnings Per Share, Diluted -0.73 USD/shares -462%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.3M USD -5%
Accounts Receivable, after Allowance for Credit Loss, Current 11.6M USD -4.9%
Inventory, Net 4.3M USD -60.6%
Other Assets, Current 1.97M USD -47.3%
Assets, Current 35.6M USD -18.5%
Property, Plant and Equipment, Net 337K USD -12.3%
Operating Lease, Right-of-Use Asset 6.37M USD -6.82%
Goodwill 914K USD 0%
Other Assets, Noncurrent 2.99M USD +14.8%
Assets 78.5M USD -12.1%
Accounts Payable, Current 12.5M USD +14.6%
Employee-related Liabilities, Current 1.2M USD -16.9%
Accrued Liabilities, Current 13.6M USD -22.7%
Contract with Customer, Liability, Current 220K USD -64.1%
Liabilities, Current 24.8M USD -8.17%
Operating Lease, Liability, Noncurrent 5.1M USD -6.88%
Other Liabilities, Noncurrent 6.54M USD -5.97%
Liabilities 52.5M USD -0.1%
Retained Earnings (Accumulated Deficit) -20.5M USD -102%
Stockholders' Equity Attributable to Parent 26.3M USD -29.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 26M USD -29.3%
Liabilities and Equity 78.5M USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.14M USD -50.7%
Net Cash Provided by (Used in) Financing Activities 2.42M USD
Net Cash Provided by (Used in) Investing Activities -58.2K USD +66.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 14.1M shares -1.73%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 227K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.3M USD -5%
Deferred Tax Assets, Valuation Allowance 21.9M USD +1.45%
Deferred Tax Assets, Gross 23.4M USD +3.12%
Operating Lease, Liability 5.48M USD -5.53%
Payments to Acquire Property, Plant, and Equipment 41.6K USD -61.2%
Lessee, Operating Lease, Liability, to be Paid 8.7M USD -8.92%
Property, Plant and Equipment, Gross 2.61M USD +9.99%
Operating Lease, Liability, Current 377K USD +17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 910K USD +8.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 836K USD -3.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.23M USD -14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 934K USD +2.67%
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 741K USD -20.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7.92M USD +82.9%
Depreciation, Depletion and Amortization 1.15M USD -8.36%
Interest Expense 534K USD -24.6%